Karl-Erik Andersson to Sexual Dysfunction, Physiological
This is a "connection" page, showing publications Karl-Erik Andersson has written about Sexual Dysfunction, Physiological.
Connection Strength
1.137
-
Andersson KE, Abdel-Hamid IA. Therapeutic targets for premature ejaculation. Maturitas. 2011 Sep; 70(1):26-33.
Score: 0.346
-
Abdel-Hamid IA, Andersson KE. Pharmacogenetics and pharmacogenomics of sexual dysfunction: current status, gaps and potential applications. Pharmacogenomics. 2009 Oct; 10(10):1625-44.
Score: 0.304
-
Andersson KE, Mulhall JP, Wyllie MG. Pharmacokinetic and pharmacodynamic features of dapoxetine, a novel drug for 'on-demand' treatment of premature ejaculation. BJU Int. 2006 Feb; 97(2):311-5.
Score: 0.236
-
Abdel-Hamid IA, Andersson KE, Salonia A. Exploration of therapeutic targets for sexual dysfunctions: lessons learned from the failed stories. Expert Opin Ther Targets. 2011 Mar; 15(3):325-40.
Score: 0.083
-
Burnett AL, Goldstein I, Andersson KE, Argiolas A, Christ G, Park K, Xin ZC. Future sexual medicine physiological treatment targets. J Sex Med. 2010 Oct; 7(10):3269-304.
Score: 0.082
-
Lue TF, Giuliano F, Montorsi F, Rosen RC, Andersson KE, Althof S, Christ G, Hatzichristou D, Hirsch M, Kimoto Y, Lewis R, McKenna K, MacMahon C, Morales A, Mulcahy J, Padma-Nathan H, Pryor J, de Tejada IS, Shabsigh R, Wagner G. Summary of the recommendations on sexual dysfunctions in men. J Sex Med. 2004 Jul; 1(1):6-23.
Score: 0.053
-
De Nunzio C, Roehrborn CG, Andersson KE, McVary KT. Erectile Dysfunction and Lower Urinary Tract Symptoms. Eur Urol Focus. 2017 10; 3(4-5):352-363.
Score: 0.033